Insilico Medicine receives IND approval from FDA for ISM8969, an AI-empowered potential best-in-class NLRP3 inhibitor – EurekAlert! / Artificial intelligence (AI) / By hi@aiweekly.co.in Insilico Medicine receives IND approval from FDA for ISM8969, an AI-empowered potential best-in-class NLRP3 inhibitor EurekAlert!
